A panelist discusses how tumor heterogeneity (both spatial and temporal) affects molecular testing reliability in ovarian cancer, highlighting that although most biomarkers show little heterogeneity, ...

Tumour progression and spread are influenced by a variety of factors. These include communication between cells, the presence of differing types of cellular lineage in a cancer (tumour heterogeneity) ...

Not all tumour cells the same Tumours aren't made up of just one cell type – they're a mix of different cells that grow and respond to treatment in different ways. This diversity, or heterogeneity, ...

Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and ...

In a new study presented at the American Association for Cancer Research (AACR) Annual Meeting and published in Blood Cancer Discovery, titled, “Single-cell Transcriptional Atlas of Human ...

Breast cancer remains one of the most prevalent and life-threatening forms of cancer, impacting millions worldwide. This malignancy's heterogeneity and complexity have long posed significant ...

Editor's note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat cancer, enabling more ...

In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature two ...

Metastatic ILC shows significant biomarker heterogeneity, limiting single biopsy reliability and highlighting challenges in detection and monitoring.

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.